A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trialDaisuke Tomizawa, Katsuyoshi Koh, Takako Miyamura et al.|Blood|2020Cited by 102
Bile acid modulates transepithelial permeability via the generation of reactive oxygen species in the Caco-2 cell lineYoshio Araki, Tadao Bamba, Takuji Katoh et al.|Free Radical Biology and Medicine|2005Cited by 101
Autoimmunity and persistent RAS-mutated clones long after the spontaneous regression of JMMLMasatoshi Takagi, Shuki Mizutani, Jun Piao et al.|Leukemia|2013Cited by 29
High event‐free survival rate with minimum‐dose‐anthracycline treatment in childhood acute promyelocytic leukaemia: a nationwide prospective study by the Japanese Paediatric Leukaemia/Lymphoma Study GroupHiroyuki Takahashi, Souichi Adachi, Tomoyuki Watanabe et al.|British Journal of Haematology|2016Cited by 21
Early Phase Administration of Hematopoietic Stem Cell Transplantation to Prevent Early Relapse for Infants with Acute Lymphoblastic Leukemia and MLL Gene Rearrangement; a Report From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Trial MLL03Katsuyoshi Koh, Eiichi Ishii, Daisuke Tomizawa et al.|Blood|2010Cited by 2